Literature DB >> 27708966

Vaccination recommendations for adult patients with rheumatic diseases.

Mine Durusu Tanrıöver1, Servet Akar2, Nuran Türkçapar3, Ömer Karadağ4, İhsan Ertenli4, Sedat Kiraz4.   

Abstract

Infectious diseases in any age group can be successfully prevented through immunization. Protection provided through immunization in childhood decreases over the years. Immunization in adulthood is important because of the growing elderly population, chronic diseases, and globalization. Recommendations on this subject are being constantly updated through scientific guidelines. Immunization in adulthood is also important in rheumatology. There is an increased risk not only of infection in rheumatic diseases but also of infections being more severe. Most infections, and their frequently observed complications, are among those diseases that can be prevented through immunization. The type of immunization, immunosuppressive/immunomodulatory therapy received by the patient, disease activity, and presence of chronic diseases affect the immunization process in patients with rheumatic diseases. This review will consider the immunization process followed in rheumatic diseases and also refer to its application.

Entities:  

Keywords:  Vaccination; adult; rheumatic disease

Year:  2015        PMID: 27708966      PMCID: PMC5042271          DOI: 10.5152/eurjrheum.2016.16100

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  20 in total

Review 1.  Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

Authors:  M Bijl; N Agmon-Levin; J-M Dayer; E Israeli; M Gatto; Y Shoenfeld
Journal:  Autoimmun Rev       Date:  2011-10-22       Impact factor: 9.754

2.  Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine.

Authors:  Thomas Hügle; Andreas Bircher; Ulrich A Walker
Journal:  Rheumatology (Oxford)       Date:  2011-12-09       Impact factor: 7.580

Review 3.  Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

Authors:  S van Assen; O Elkayam; N Agmon-Levin; R Cervera; M F Doran; M Dougados; P Emery; P Geborek; J P A Ioannidis; D R W Jayne; C G M Kallenberg; U Müller-Ladner; Y Shoenfeld; L Stojanovich; G Valesini; N M Wulffraat; M Bijl
Journal:  Autoimmun Rev       Date:  2010-12-20       Impact factor: 9.754

Review 4.  Immunosenescence: Implications for vaccination programmes in adults.

Authors:  Pierre Olivier Lang; Sheila Govind; Jean Pierre Michel; Richard Aspinall; Wayne A Mitchell
Journal:  Maturitas       Date:  2011-02-12       Impact factor: 4.342

Review 5.  Measles still spreads in Europe: who is responsible for the failure to vaccinate?

Authors:  P Carrillo-Santisteve; P L Lopalco
Journal:  Clin Microbiol Infect       Date:  2012-08-27       Impact factor: 8.067

6.  Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.

Authors:  C Confavreux; S Suissa; P Saddier; V Bourdès; S Vukusic
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

7.  Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

Authors:  Michele F Doran; Cynthia S Crowson; Gregory R Pond; W Michael O'Fallon; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2002-09

8.  Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

Authors:  Sander van Assen; Albert Holvast; Cornelis A Benne; Marcel D Posthumus; Miek A van Leeuwen; Alexandre E Voskuyl; Marlies Blom; Anke P Risselada; Aalzen de Haan; Johanna Westra; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Rheum       Date:  2010-01

9.  Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.

Authors:  William A Blumentals; Anna Arreglado; Pavel Napalkov; Stephen Toovey
Journal:  BMC Musculoskelet Disord       Date:  2012-08-27       Impact factor: 2.362

10.  Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects.

Authors:  Lee Tay; Francisco Leon; George Vratsanos; Ralph Raymond; Michael Corbo
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  6 in total

1.  Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?

Authors:  Reinhart Speeckaert; Jo Lambert; Luis Puig; Marijn Speeckaert; Hilde Lapeere; Sofie De Schepper; Nanja van Geel
Journal:  Drugs R D       Date:  2021-06-09

Review 2.  The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

Authors:  Yu Bin Seo; Su Jin Moon; Chan Hong Jeon; Joon Young Song; Yoon Kyoung Sung; Su Jin Jeong; Ki Tae Kwon; Eu Suk Kim; Jae Hoon Kim; Hyoun Ah Kim; Dong Jin Park; Sung Hoon Park; Jin Kyun Park; Joong Kyong Ahn; Ji Seon Oh; Jae Won Yun; Joo Hyun Lee; Hee Young Lee; Min Joo Choi; Won Suk Choi; Young Hwa Choi; Jung Hyun Choi; Jung Yeon Heo; Hee Jin Cheong; Shin Seok Lee
Journal:  Infect Chemother       Date:  2020-06

Review 3.  Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.

Authors:  Hesham Abboud; Crystal Zheng; Indrani Kar; Claire Kaori Chen; Crystal Sau; Alessandro Serra
Journal:  Mult Scler Relat Disord       Date:  2020-06-02       Impact factor: 4.339

Review 4.  Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases.

Authors:  Ahmad AlEnizi; Khaled AlSaeid; Adel Alawadhi; Eiman Hasan; Entesar H Husain; Ahmad AlFadhli; Aqeel Ghanem; Fatemah Abutiban; Yaser Ali; Adeeba Al-Herz; Khuloud Mohammed; Waleed Alkandari; Ali Aldei; Hebah Alhajeri; Ahmad Dehrab; Sawsan Hayat
Journal:  Int J Rheumatol       Date:  2018-05-13

5.  Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.

Authors:  Valéria Valim; Ketty Lysie Libardi Lira Machado; Samira Tatiyama Miyamoto; Arthur Dalmaso Pinto; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; João Gabriel Fragoso Dias; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Ismael Artur da Costa-Rocha; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Maria de Lourdes de Sousa Maia; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Thays Zanon Casagrande; Karine Gadioli Oliveira; Bruna Costa da Mata Moura; Fernanda Nicole-Batista; Luiza Correa Rodrigues; Thalles Brandão Clemente; Enan Sales Magalhães; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Carolina Zorzanelli Costa; Raquel Altoé Giovelli; Leticia Resende Brandão; Elizandra Tomazela Laurenti Polito; Ingrid de Oliveira Koehlert; Brunela Passos Borjaille; Daniela Bergamim Pereira; Laiza Hombre Dias; Daniela Linhares Merlo; Luiz Fellipe Favoreto Genelhu; Flavia Zon Pretti; Maryella Dos Santos Giacomin; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Lícia Maria Henrique da Mota; Olindo Assis Martins-Filho
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

Review 6.  COVID-19 and immunosuppressive therapy in dermatology.

Authors:  Robert A Schwartz; Swetalina Pradhan; Dedee F Murrell; Mohammad Jafferany; Olga Y Olisova; Konstantin M Lomonosov; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-09-03       Impact factor: 3.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.